Episode
Global Shift: Outsourcing Clinical Trials In A Changing World with Heike Schoen
- Published
- Jan 29, 2026
- Duration seconds
- 1681
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-cog-review-building-better-clinical-studies-7614513/episodes/global-shift-outsourcing-clinical-trials-in-a-changing-world-with-heike-schoen/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-cog-review-building-better-clinical-studies-7614513/global-shift-outsourcing-clinical-trials-in-a-changing-world-with-heike-schoen.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Navigating Global Clinical Trial Outsourcing: Risk, Strategy & CRO Partnerships in a Changing World Gain operational clarity on the evolving landscape of clinical trial outsourcing—discover the risk factors, partnership models, and geographic strategies reshaping CRO selection and clinical operations. Guest Heike Schoen, CEO, Loomis International ( LinkedIn ) 20+ years in clinical operations, global trial strategy, and vendor management Bart Scheerder, Host Authority in European clinical operations and outsourcing trends David Jones, Head of Content, The PBC Group Recorded live at COG Europe, Amsterdam. Episode Overview This episode of The COG Review: Building Better Clinical Studies features Heike Schoen, CEO of Loomis International, in a keynote session from COG Europe. The discussion centers on the global shift in clinical trial outsourcing, with a sharp focus on how sponsors and CROs are adapting to rapid changes in regulation, geopolitics, and technological innovation. Heike Schoen explores the evolution of sponsor–CRO partnerships, from transactional service agreements to nuanced hybrid models, where flexibility and deep therapeutic expertise are essential for success. Practical examples from Novartis–PPD and Moderna–Medidata illustrate both functional service partnerships and the impact of digital, decentralized trials. Key areas include CRO selection strategies for emerging markets, navigating regulatory changes, and building operational agility in the face of supply chain fragility and geopolitical risk. Insights are tailored for professionals involved in clinical operations best practices, outsourcing decisions, and those seeking to optimize clinical studies through smarter partnerships and technology use. The session closes with real-world challenges and…